Asthma and Stepwise Management Asthma is a common disorder that affects around 1 in 13 Americans today (Asthma facts and figures, 2018). Although there is no cure for asthma, the condition can be managed effectively using various methods, including most especially a stepwise approach. The purpose of this paper is to provide a description of long-term control and quick relief treatment options for asthma sufferers and side effects such interventions can

Asthma is an obstructive airway disease that is reversible. It is characterized by hyper-responsiveness of the airways, resulting in chronic inflammation and bronchospasm. Chronic bronchitis and emphysema are other examples of obstructive airway diseases that are reversible. (CH, 2011) Asthma can either be extrinsic, also known as atopic asthma, or intrinsic, which is also called non-atopic asthma. Extrinsic asthma is the more common variety, comprising of about seventy percent of all

Introduction Asthma is a serious chronic illness that can wreak havoc in a person’s life. Whether young or old, treatment options can either help or hurt an asthma patient. Doctors and health professionals sometimes use the stepwise approach to help narrow down appropriate treatment options. While the stepwise approach has its place in treating asthma patients, there is also a need to research what recent options there are to help patients

Long-term and Quick Relief Treatment Options Bronchial asthma is a chronic inflammation of someone’s bronchial tubes (Szefler, Holguin, & Wechsler, 2017). Inflammation of respiratory airways leads to narrowing and swelling of the bronchi resulting in difficult breathing. Some of the symptoms of asthma are coughing and wheezing, shortness of breath, and chest pain/tightness (Szefler, Holguin, & Wechsler, 2017). There are various treatments for bronchial inflammation. Some are long-term, and some are

Asthma and Stepwise Management Long-term control and quick relief treatment, and the effect on patients Health care comprises of giving treatment for acute asthmatic incidents and management of persistent symptoms, which includes exercise-provoked and nocturnal asthmatic symptoms. Pharmacological controls entail the application of management mechanisms: inhaled corticosteroids, theophylline, long-acting bronchodilators (anticholinergics and beta-agonists), leukotriene transformers and the more current tactics for example the utilization of Ige, that is, anti-immunoglobulin E. antibodies (Omalizumab),

Improving Health for Children With Asthma Childhood Asthma Improving Health Outcomes for Inner-City Children with Asthma Improving Health Outcomes for Inner-City Children with Asthma Centers for Disease Control and Prevention (CDC) engages in active surveillance of childhood asthma because it is prevalent, contributes significantly to childhood morbidity, and imposes an economic burden on families (CDC, 2012). The main recommendations for diagnosing and managing asthma by the National Heart, Lung, and Blood Institute (NHLBI) and